4//SEC Filing
Madan Ajay 4
Accession 0001209191-22-008061
CIK 0001658247other
Filed
Feb 8, 7:00 PM ET
Accepted
Feb 9, 5:00 PM ET
Size
5.2 KB
Accession
0001209191-22-008061
Insider Transaction Report
Form 4
Madan Ajay
Chief Development Officer
Transactions
- Sale
Common Stock
2022-02-07$17.83/sh−13,411$239,085→ 172,045 total
Footnotes (2)
- [F1]The sale reported in this Form 4 was effected automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person at least 30 days prior to the trading date.
- [F2]Represents the weighted average sale price for the entire number of shares sold. The actual sales prices range between $17.170 and $18.015. Detailed information on the exact number of shares sold at each sale price can be obtained from the issuer upon request.
Documents
Issuer
Crinetics Pharmaceuticals, Inc.
CIK 0001658247
Entity typeother
Related Parties
1- filerCIK 0001807856
Filing Metadata
- Form type
- 4
- Filed
- Feb 8, 7:00 PM ET
- Accepted
- Feb 9, 5:00 PM ET
- Size
- 5.2 KB